Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Health Assessment of Electronic Waste Workers in Chile: Participant Characterization.

Yohannessen K, Pinto-Galleguillos D, Parra-Giordano D, Agost A, Valdés M, Smith LM, Galen K, Arain A, Rojas F, Neitzel RL, Ruiz-Rudolph P.

Int J Environ Res Public Health. 2019 Jan 29;16(3). pii: E386. doi: 10.3390/ijerph16030386.

2.

The pathogenesis of obesity.

Oussaada SM, van Galen KA, Cooiman MI, Kleinendorst L, Hazebroek EJ, van Haelst MM, Ter Horst KW, Serlie MJ.

Metabolism. 2019 Mar;92:26-36. doi: 10.1016/j.metabol.2018.12.012. Epub 2019 Jan 9.

PMID:
30639246
3.

Sports participation and physical activity in patients with von Willebrand disease.

Atiq F, Mauser-Bunschoten EP, Eikenboom J, van Galen KPM, Meijer K, de Meris J, Cnossen MH, Beckers EAM, Laros-van Gorkom BAP, Nieuwenhuizen L, van der Bom JG, Fijnvandraat K, Leebeek FWG; WiN study group.

Haemophilia. 2019 Jan;25(1):101-108. doi: 10.1111/hae.13629. Epub 2018 Nov 14.

PMID:
30427095
4.

The prevalence and burden of hand and wrist bleeds in von Willebrand disease.

van Deukeren D, Mauser-Bunschoten EP, Schutgens REG, Eikenboom J, Meijer K, Fijnvandraat K, Laros-van Gorkom BAP, Cnossen M, de Meris J, van der Bom JG, Leebeek FWG, van Galen KPM.

Haemophilia. 2019 Jan;25(1):e35-e38. doi: 10.1111/hae.13632. Epub 2018 Nov 5. No abstract available.

PMID:
30394622
5.

Long-Term Outcome after Joint Bleeds in Von Willebrand Disease Compared to Haemophilia A: A Post Hoc Analysis.

van Galen KPM, Timmer M, de Kleijn P, Leebeek FWG, Foppen W, Schutgens REG, Eikenboom J, Meijer K, Fijnvandraat K, Laros-van Gorkom BAP, Twisk JW, Mauser-Bunschoten EP, Fischer K; WiN Studygroup.

Thromb Haemost. 2018 Oct;118(10):1690-1700. doi: 10.1055/s-0038-1670704. Epub 2018 Oct 1.

PMID:
30273954
6.

Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions.

Engelen ET, Schutgens RE, Mauser-Bunschoten EP, van Es RJ, van Galen KP.

Cochrane Database Syst Rev. 2018 Jul 2;7:CD012293. doi: 10.1002/14651858.CD012293.pub2. Review.

PMID:
29963686
7.

Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease.

Atiq F, Meijer K, Eikenboom J, Fijnvandraat K, Mauser-Bunschoten EP, van Galen KPM, Nijziel MR, Ypma PF, de Meris J, Laros-van Gorkom BAP, van der Bom JG, de Maat MP, Cnossen MH, Leebeek FWG; WiN study group.

Br J Haematol. 2018 Jul;182(1):93-105. doi: 10.1111/bjh.15277. Epub 2018 May 16.

8.

Pancreas Transplantation From Pediatric Donors: A Single-Center Experience.

Spaggiari M, Di Bella C, Di Cocco P, Campara M, Galen K, Gheza F, Oberholzer J, Benedetti E, Tzvetanov I.

Transplantation. 2018 Oct;102(10):1732-1739. doi: 10.1097/TP.0000000000002208.

PMID:
29620617
9.

The role of central dopamine and serotonin in human obesity: lessons learned from molecular neuroimaging studies.

van Galen KA, Ter Horst KW, Booij J, la Fleur SE, Serlie MJ.

Metabolism. 2018 Aug;85:325-339. doi: 10.1016/j.metabol.2017.09.007. Epub 2017 Sep 29. Review.

PMID:
28970033
10.

Long-term impact of joint bleeds in von Willebrand disease: a nested case-control study.

van Galen KPM, de Kleijn P, Foppen W, Eikenboom J, Meijer K, Schutgens REG, Fischer K, Cnossen MH, de Meris J, Fijnvandraat K, van der Bom JG, Laros-van Gorkom BAP, Leebeek FWG, Mauser-Bunschoten EP; Win study group.

Haematologica. 2017 Sep;102(9):1486-1493. doi: 10.3324/haematol.2017.168617. Epub 2017 Jun 1.

11.

Joint assessment in von Willebrand disease. Validation of the Haemophilia Joint Health score and Haemophilia Activities List.

van Galen KPM, Timmer MA, de Kleijn P, Fischer K, Foppen W, Schutgens REG, Eikenboom J, Meijer K, Cnossen MH, Fijnvandraat K, van der Bom JG, Laros-van Gorkom BAP, Leebeek FWG, Mauser-Bunschoten EP, Win Study Group OBOT.

Thromb Haemost. 2017 Aug 1;117(8):1465-1470. doi: 10.1160/TH16-12-0967. Epub 2017 May 11.

PMID:
28492695
12.

Methods for quantifying adipose tissue insulin resistance in overweight/obese humans.

Ter Horst KW, van Galen KA, Gilijamse PW, Hartstra AV, de Groot PF, van der Valk FM, Ackermans MT, Nieuwdorp M, Romijn JA, Serlie MJ.

Int J Obes (Lond). 2017 Aug;41(8):1288-1294. doi: 10.1038/ijo.2017.110. Epub 2017 May 3.

PMID:
28465607
13.

The association of haemophilic arthropathy with Health-Related Quality of Life: a post hoc analysis.

Fischer K, de Kleijn P, Negrier C, Mauser-Bunschoten EP, van der Valk PR, van Galen KP, Willemze A, Schutgens R.

Haemophilia. 2016 Nov;22(6):833-840. doi: 10.1111/hae.13120. Epub 2016 Oct 26.

PMID:
27785891
14.

Maternal vitamin B12 deficiency and abnormal cell-free DNA results in pregnancy.

Schuring-Blom H, Lichtenbelt K, van Galen K, Elferink M, Weiss M, Vermeesch JR, Page-Christiaens L.

Prenat Diagn. 2016 Aug;36(8):790-3. doi: 10.1002/pd.4863. Epub 2016 Jul 17. No abstract available.

PMID:
27328203
15.

Discontinuing early prophylaxis in severe haemophilia leads to deterioration of joint status despite low bleeding rates.

Nijdam A, Foppen W, De Kleijn P, Mauser-Bunschoten EP, Roosendaal G, van Galen KP, Schutgens RE, van der Schouw YT, Fischer K.

Thromb Haemost. 2016 May 2;115(5):931-8. doi: 10.1160/TH15-08-0637. Epub 2016 Jan 21.

PMID:
26791021
16.

Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.

van Galen KP, Engelen ET, Mauser-Bunschoten EP, van Es RJ, Schutgens RE.

Cochrane Database Syst Rev. 2015 Dec 24;(12):CD011385. doi: 10.1002/14651858.CD011385.pub2. Review.

PMID:
26704192
17.

Joint surgery in von Willebrand disease: a multicentre cross-sectional study.

van Galen KPM, Meijer K, Vogely HC, Eikenboom J, Schutgens REG, Cnossen MH, Fijnvandraat K, van der Bom JG, Laros-van Gorkom BAP, Leebeek FWG, Mauser-Bunschoten EP; WiN study group.

Haemophilia. 2016 Mar;22(2):256-262. doi: 10.1111/hae.12834. Epub 2015 Nov 9.

PMID:
26551280
18.

Thalidomide for treatment of gastrointestinal bleedings due to angiodysplasia: a case report in acquired von Willebrand syndrome and review of the literature.

Engelen ET, van Galen KP, Schutgens RE.

Haemophilia. 2015 Jul;21(4):419-29. doi: 10.1111/hae.12701. Epub 2015 Apr 30. Review.

PMID:
25929157
19.

Joint bleeds in von Willebrand disease patients have significant impact on quality of life and joint integrity: a cross-sectional study.

van Galen KP, Sanders YV, Vojinovic U, Eikenboom J, Cnossen MH, Schutgens RE, van der Bom JG, Fijnvandraat K, Laros-Van Gorkom BA, Meijer K, Leebeek FW, Mauser-Bunschoten EP; WiN Study Group.

Haemophilia. 2015 May;21(3):e185-92. doi: 10.1111/hae.12670. Epub 2015 Apr 9.

PMID:
25854528
20.

First report of inhibitory von Willebrand factor alloantibodies in type 2B von Willebrand disease.

Baaij M, van Galen KP, Urbanus RT, Nigten J, Eikenboom JH, Schutgens RE.

Br J Haematol. 2015 Nov;171(3):424-7. doi: 10.1111/bjh.13395. Epub 2015 Apr 7. No abstract available.

PMID:
25851809
21.

The Effect on Treatment Adherence of Administering Drugs as Fixed-Dose Combinations versus as Separate Pills: Systematic Review and Meta-Analysis.

van Galen KA, Nellen JF, Nieuwkerk PT.

AIDS Res Treat. 2014;2014:967073. doi: 10.1155/2014/967073. Epub 2014 Sep 4. Review.

22.

End-stage cardiomyopathy because of hereditary hemochromatosis successfully treated with erythrocytapheresis in combination with left ventricular assist device support.

Rombout-Sestrienkova E, De Jonge N, Martinakova K, Klöpping C, van Galen KP, Vink A, Wajon EM, Smit WM, van Bree C, Koek GH.

Circ Heart Fail. 2014 May;7(3):541-3. doi: 10.1161/CIRCHEARTFAILURE.114.001198. No abstract available.

PMID:
24847131
23.

A novel small-molecule enantiomeric analogue of traditional (-)-morphinans has specific TLR9 antagonist properties and reduces sterile inflammation-induced organ damage.

Hoque R, Farooq A, Malik A, Trawick BN, Berberich DW, McClurg JP, Galen KP, Mehal W.

J Immunol. 2013 Apr 15;190(8):4297-304. doi: 10.4049/jimmunol.1202184. Epub 2013 Mar 15.

24.

Hemophilic arthropathy in patients with von Willebrand disease.

van Galen KP, Mauser-Bunschoten EP, Leebeek FW.

Blood Rev. 2012 Nov;26(6):261-6. doi: 10.1016/j.blre.2012.09.002. Epub 2012 Sep 23. Review.

PMID:
23010260
25.

Implantable defibrillators in cardiac amyloidosis.

van Galen KP, van Dijk J, Regelink JC, Huijgens PC, Minnema MC, Zweegman S.

Int J Cardiol. 2013 May 10;165(2):371-3. doi: 10.1016/j.ijcard.2012.08.028. Epub 2012 Sep 16. No abstract available.

PMID:
22989609
26.

Von Willebrand factor deficiency and atherosclerosis.

van Galen KP, Tuinenburg A, Smeets EM, Schutgens RE.

Blood Rev. 2012 Sep;26(5):189-96. doi: 10.1016/j.blre.2012.05.002. Epub 2012 Jun 19. Review.

PMID:
22721874
27.

Letter from van Galen et al regarding article, "Cardiac amyloidosis: a treatable disease often overlooked".

van Galen KP, van Dijk J, Zweegman S.

Circulation. 2012 Apr 3;125(13):e538; author reply e539. doi: 10.1161/CIRCULATIONAHA.111.074229. No abstract available.

PMID:
22474317
28.

Exogenous fluorescent tracer agents based on pegylated pyrazine dyes for real-time point-of-care measurement of glomerular filtration rate.

Poreddy AR, Neumann WL, Freskos JN, Rajagopalan R, Asmelash B, Gaston KR, Fitch RM, Galen KP, Shieh JJ, Dorshow RB.

Bioorg Med Chem. 2012 Apr 15;20(8):2490-7. doi: 10.1016/j.bmc.2012.03.015. Epub 2012 Mar 10.

PMID:
22459210
29.

Hydrophilic pyrazine dyes as exogenous fluorescent tracer agents for real-time point-of-care measurement of glomerular filtration rate.

Rajagopalan R, Neumann WL, Poreddy AR, Fitch RM, Freskos JN, Asmelash B, Gaston KR, Galen KP, Shieh JJ, Dorshow RB.

J Med Chem. 2011 Jul 28;54(14):5048-58. doi: 10.1021/jm200257k. Epub 2011 Jun 27.

PMID:
21667980
30.

Pancreatic pseudocyst in an adult patient after treatment with pegylated asparaginase.

van Galen KP, Zweegman S, Ossenkoppele GJ.

Br J Haematol. 2011 Mar;152(6):676. doi: 10.1111/j.1365-2141.2010.08513.x. Epub 2011 Jan 14. No abstract available.

PMID:
21623759
31.

Prognostic factors in patients with breast cancer and malignant pleural effusion.

van Galen KP, Visser HP, van der Ploeg T, Smorenburg CH.

Breast J. 2010 Nov-Dec;16(6):675-7. doi: 10.1111/j.1524-4741.2010.00986.x. No abstract available.

PMID:
21070453
32.

Long-term follow-up of tandem autologous stem-cell transplantation in multiple myeloma.

Regelink JC, van Roessel CH, van Galen KP, Ossenkoppele GJ, Huijgens PC, Zweegman S.

J Clin Oncol. 2010 Dec 10;28(35):e741-3; author reply e744-5. doi: 10.1200/JCO.2010.31.5515. Epub 2010 Nov 8. No abstract available.

PMID:
21060027
33.

[Hepatic encephalopathy following a Whipple operation].

van Galen KP, Stam F, van Oijen AH.

Ned Tijdschr Geneeskd. 2009;153:A463. Dutch.

PMID:
19857276
34.

[Variable presentation of antiglomerular basement membrane (anti-GBM) disease: rapid recognition vitally important].

van Galen KP, Oswald LM, van den Aardweg JG, Stam F, van den Berg JG, Bax WA.

Ned Tijdschr Geneeskd. 2009;153:B365. Dutch.

PMID:
19785783
35.

[Variable presentation of antiglomerular basement membrane (anti-GBM) disease: rapid recognition vitally important].

van Galen KP, Oswald LM, van den Aardweg JG, Stam F, van den Berg JG, Bax WA.

Ned Tijdschr Geneeskd. 2009 May 30;153(22):1068-73. Dutch. No abstract available.

PMID:
19757750
36.

Fluorescence-enhanced europium-diethylenetriaminepentaacetic (DTPA)-monoamide complexes for the assessment of renal function.

Chinen LK, Galen KP, Kuan KT, Dyszlewski ME, Ozaki H, Sawai H, Pandurangi RS, Jacobs FG, Dorshow RB, Rajagopalan R.

J Med Chem. 2008 Feb 28;51(4):957-62. doi: 10.1021/jm070842+. Epub 2008 Feb 6.

PMID:
18251490
37.

Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles.

Klibanov AL, Rasche PT, Hughes MS, Wojdyla JK, Galen KP, Wible JH Jr, Brandenburger GH.

Invest Radiol. 2004 Mar;39(3):187-95.

PMID:
15076011
38.

A newly identified role for superoxide in inflammatory pain.

Wang ZQ, Porreca F, Cuzzocrea S, Galen K, Lightfoot R, Masini E, Muscoli C, Mollace V, Ndengele M, Ischiropoulos H, Salvemini D.

J Pharmacol Exp Ther. 2004 Jun;309(3):869-78. Epub 2004 Feb 26.

PMID:
14988418
39.

Albumin-binding MR blood pool agents as MRI contrast agents in an intracranial mouse glioma model.

Adzamli K, Yablonskiy DA, Chicoine MR, Won EK, Galen KP, Zahner MC, Woolsey TA, Ackerman JJ.

Magn Reson Med. 2003 Mar;49(3):586-90.

40.

Microbubbles induce renal hemorrhage when exposed to diagnostic ultrasound in anesthetized rats.

Wible JH Jr, Galen KP, Wojdyla JK, Hughes MS, Klibanov AL, Brandenburger GH.

Ultrasound Med Biol. 2002 Nov-Dec;28(11-12):1535-46.

PMID:
12498949
41.

Detection of individual microbubbles of an ultrasound contrast agent: fundamental and pulse inversion imaging.

Klibanov AL, Rasche PT, Hughes MS, Wojdyla JK, Galen KP, Wible JH Jr, Brandenburger GH.

Acad Radiol. 2002 Aug;9 Suppl 2:S279-81. No abstract available.

PMID:
12188248
42.

Toxicological assessment of gadoversetamide injection (OptiMARK), a new contrast-enhancement agent for use in magnetic resonance imaging.

Wible JH Jr, Troup CM, Hynes MR, Galen KP, MacDonald JR, Barco SJ, Wojdyla JK, Periasamy MP, Adams MD.

Invest Radiol. 2001 Jul;36(7):401-12.

PMID:
11496095
43.

Cardiovascular effects caused by rapid administration of gadoversetamide injection in anesthetized dogs.

Wible JH Jr, Galen KP, Wojdyla JK.

Invest Radiol. 2001 May;36(5):292-8.

PMID:
11394361
44.

Synthesis and preliminary evaluation of MP-2269: a novel, nonaromatic small-molecule blood-pool MR contrast agent.

Wallace RA, Haar JP Jr, Miller DB, Woulfe SR, Polta JA, Galen KP, Hynes MR, Adzamli K.

Magn Reson Med. 1998 Nov;40(5):733-9.

PMID:
9797157
45.

Manganese-substituted hydroxyapatites coated with polyethylene glycol diphosphonate: potential blood-pool agents for magnetic resonance imaging.

Adzamli K, Dorshow RB, Hynes MR, Nosco DL, Beaty-Nosco JA, Fallis S, Galen KP, Levine JA, Nema S, Polta J, Adams MD.

Acad Radiol. 1996 Aug;3 Suppl 2:S349-52. No abstract available.

PMID:
8796601
46.

Manganese hydroxylapatite as a potential magnetic resonance contrast agent for liver imaging.

Braddock-Wilking J, Nosco DL, Hynes MR, Galen KP, Dorshow RB, Adams MD.

Invest Radiol. 1994 Jun;29 Suppl 2:S251-4. No abstract available.

PMID:
7928248
47.

Assessing psychiatric patients' competency to agree to treatment plans.

Galen KD.

Hosp Community Psychiatry. 1993 Apr;44(4):361-4. Review.

PMID:
8462943

Supplemental Content

Support Center